Don't have an ISSCR Connect account? You can register for a free, public account that will give you access to the Public Channel.

Click here to be taken to the registration form.

Welcome to ISSCR Connect. This online gateway provides member access to webcasts of the latest stem cell research from around the world through the Stem Cell Professionals channel and free, public access to presentations on the Stem Cells in Focus channel that promote the awareness and understanding of stem cell research and the issues that surround it.

Upcoming Programming

The ISSCR is pleased to launch the "Translational Know-How" series.

This series, developed with the help of the ISSCR’s Industry Committee, is intended to share new knowledge and experiences in translational stem cell research and therapy development. Areas of emphasis will include innovative and emerging cellular technologies and their translational applications, industry initiatives to develop the best practices and standards around the use of these technologies and applications, and the evolving global regulatory strategies and national regulatory landscape.

From the Translational Know-How Series: Comprehensive in vitro Proarrhythmia Assay (CiPA) and the Use of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Gary Gintant, PhD, Jennifer Pierson, and Norman Stockbridge, MD, PhD
Abbvie (GG), HESI (JP), and the U.S. FDA (NS)

18 November, 2015
12:00 p.m. Central (U.S.)

Cardiovascular toxicity, especially proarrhythmia, is a major reason why investigational new drugs fail to gain approval for clinical use. An international initiative between regulatory agencies and pharmaceutical companies is working to develop a more effective and predictive screening process using human pluripotent stem cell derived cardiomyoctes. 

This in an open-access program and will be webcast on the Public Channel. To register and view, login to ISSCR Connect.


From the Translational Know-How Series: Cellular Therapy Regulations in the U.S.

Joyce L Frey-Vasconcells, PhD and Lei Xu, MD, PhD
Frey-Vasconcells Consultants, LLC (JLF-V) and the U.S. FDA (LX) 

7 December, 2015
1:00 p.m. Central (U.S.) / 13:00
This program, is the first in a four part series that will explore the cellular therapy regulations across the globe.

This in an open-access program and will be webcast on the Public Channel. To register and view, login to ISSCR Connect.

Regenerative Medicine and the Eye: Clinical Trials - The Future

Brian Ballios, MD
University of Toronto

4 December, 2015
1:00 p.m. Central (U.S.) / 15:00
Join the ISSCR to explore the new frontiers of regenerative medicine being applied to vision research. In the third part of a three-part series, Dr. Brian Ballios will discuss some of the clinical trials in which scientists are applying stem cell-derived therapies to regenerate and repair the light-sensitive tissue of the eye - the retina.

This in an open-access program and will be webcast on the Public Channel. To register and view, login to ISSCR Connect.

On Demand Programming on the Stem Cells in Focus channel

Regenerative Medicine for Multiple Sclerosis

Paul Tesar, PhD
Case Western Reserve University

Multiple sclerosis (MS) affects about 2.3 million people worldwide and is thought to be caused by an immune system-mediated attack on the body that damages the insulation around the nerves, known as myelin, and the cells that produce it, known as oligodendrocytes. Dr. Paul Tesar and his research team have developed a novel method to identify drugs that can stimulate stem cells to form new oligodendrocytes and form new insulation (myelin). Join us for this live webcast to hear Dr. Tesar talk about his latest research.
Dr. Paul Tesar is the recipient of the 2015 ISSCR Outstanding Young Investigator Award.

Regenerative Medicine Efforts for Wounded Warriors

Anthony Atala, MD
Wake Forest University Institute for Regenerative Medicine

Regenerative medicine, the process of replacing dead or damaged tissues to restore normal function, was once thought to be science fiction. A team of researchers at the Wake Forest Institute for Regenerative Medicine, led by Dr. Anthony Atala, are working to turn science fiction into science fact. Please join us for this live webcast as Dr. Atala presents some of the latest advances in regenerative medicine.

Upcoming Programming on the Stem Cell Professionals channel

Check back for upcoming, live presentations on the Stem Cell Professionals channel.

On Demand Programming on the Stem Cell Professionals channel

Stem Cell Transplants for Parkinson's Disease - What's the Deal?

Roger Barker, MBBS, MRCP, PhD
Professor of Clinical Neuroscience, University of Cambridge and Honorary Consultant Neurologist at Addenbrooke's Hospital, Cambridge, U.K.

Initiating Cell-Based Therapy Trials - How Do You Know You Are There?

Sowmya Viswanathan, PhD
Assistant professor, Institute of Biomaterials and Biomedical Engineering, University of Toronto and Associate Director of the Cell Therapy Program, University Health Network, Canada

Hematopoietic Cell Engineering for the Treatment of Hemoglobinopathies: Path to the Clinic

Isabelle Riviere, PhD
Director of the Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York, U.S.

For more on demand presentations, click the Stem Cell Professionals link above or click here

International Society for Stem Cell Research
5215 Old Orchard Road, Suite 270
Skokie, Illinois, USA 60077
+1 224-592-5700